Crosseal market seen growing on surgery demand, injuries and regional expansion

The Business Research Company says the Crosseal market is set for long-term growth as more surgeries, injury cases and minimally invasive procedures increase demand for fibrin sealants. North America led the market in 2025, while Asia Pacific is expected to grow fastest through the forecast period.

Why it matters: - Crosseal is a fibrin sealant used to control bleeding and support tissue healing during surgery. - Growth in surgical volumes and trauma care can increase demand for products that improve hemostasis and recovery. - The market outlook points to broader expansion in medical adhesives tied to aging populations, outpatient surgery and biologic tissue sealants.

What happened: - The Business Research Company released an analysis of the global Crosseal market on Nov. 2, 2026. - The report highlights long-term growth potential for a specialized segment of the medical adhesives industry. - The company said North America was the largest Crosseal market in 2025. - The company said Asia Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample of the report is available here. - The full report is available here.

The details: - Crosseal is composed of fibrinogen and thrombin. - Those components replicate the final stages of natural blood clotting. - The sealant forms a clot that seals tissue and stops bleeding. - Historic growth was tied to clinical validation of fibrin sealants, more surgical procedures and stronger demand for bleeding control. - Hospital adoption of advanced hemostatic agents also supported growth. - Regulatory approvals helped expand use of surgical sealants. - Forecast growth is linked to more orthopedic and cardiac surgeries. - Growth in outpatient surgical centers is another driver. - Patient preference for biologic sealants is also supporting demand. - Ongoing improvements in tissue adhesives are expected to lift adoption. - The aging global population is adding to surgical need. - The report flags more use of fibrin sealants during surgery, greater focus on surgical hemostasis, wider adoption of biological tissue adhesives and better outcomes in complex procedures as major trends.

Between the lines: - Rising injury rates are adding pressure on surgical systems and boosting the need for fast bleeding control. - Transport Canada reported 1,964 motor vehicle fatalities in 2023, up 1.7% from 2022. - Minimally invasive surgery is creating demand for sealants that reduce bleeding in smaller surgical fields. - The American Society of Plastic Surgeons said cosmetic minimally invasive procedures rose from 23.7 million in 2022 to 25.4 million in 2023. - Higher healthcare spending is also supporting adoption of surgical products that improve efficiency and outcomes. - UK healthcare spending increased 5.6% from 2022 to 2023 to about $317.63 billion (£292 billion). - The report adds market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspots infographics and updated trend analysis.

What's next: - Crosseal demand is likely to track growth in orthopedic, cardiac and minimally invasive procedures. - Asia Pacific could gain share if surgery volumes and healthcare investment keep rising. - Further adoption of biologic sealants and hemostatic products may continue as hospitals seek faster recovery and fewer complications.

The bottom line: - The Crosseal market is expanding on the back of more surgery, more injuries and wider use of biologic sealants.